Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ling-Yuan Kong
Affiliation
The University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
1994
Papers
78
H Index
39
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36759517
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.
Nat Commun
2023
36831427
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
Cancers (Basel)
2023
36001588
In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada.
PLoS One
2022
34110743
Utility of Whole Genome Sequencing in Assessing and Enhancing Partner Notification of Neisseria gonorrhoeae Infection.
Sex Transm Dis
2021
33571109
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme.
Sci Adv
2021
34910717
A 57-Year-Old Man with Type 1 Diabetes Mellitus and a Chronic Foot Ulcer Successfully Managed with a Remote Patient-Facing Wound Care Smartphone Application.
Am J Case Rep
2021
34272314
Contribution of AMPA Receptor-Mediated LTD in LA/BLA-CeA Pathway to Comorbid Aversive and Depressive Symptoms in Neuropathic Pain.
J Neurosci
2021
34031054
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
Clin Cancer Res
2021
34257090
Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.
CMAJ Open
2021
31633561
Foodborne transmission of Clostridioides difficile: a review.
Curr Opin Gastroenterol
2020
34240055
Prolonged empirical antibiotic therapy is correlated with bloodstream infections and increased mortality in a tertiary care hospital in Ethiopia: bacteriology testing matters.
JAC Antimicrob Resist
2020
31873309
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Nat Med
2020
33348707
MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme.
Cancers (Basel)
2020
32605912
Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.
Clin Cancer Res
2020
32721947
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.
JCI Insight
2020
32554515
Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
Clin Cancer Res
2020
30307407
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
J Clin Invest
2019
29846557
Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing.
Clin Infect Dis
2019
29947810
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
J Natl Cancer Inst
2019
31201853
The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials.
Anaerobe
2019
29307707
Travel-Related Infections Among Pregnant Travellers to the Tropics: An Overview.
J Obstet Gynaecol Can
2018
29991446
Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.
Cancer Lett
2018
29636332
Intradermal pre-exposure rabies vaccination in a Canadian travel clinic: 6-year retrospective observational study.
CMAJ Open
2018
29540433
Understanding Clostridium difficile Colonization.
Clin Microbiol Rev
2018
27765835
Immune modulatory nanoparticle therapeutics for intracerebral glioma.
Neuro Oncol
2017
28792883
Left-Middle-Lobe Pneumonia.
N Engl J Med
2017
27713131
Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.
Oncotarget
2016
26658052
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
Neuro Oncol
2016
26323609
PD-L1 expression and prognostic impact in glioblastoma.
Neuro Oncol
2016
25525055
Rapid progression to gummatous syphilitic hepatitis and neurosyphilis in a patient with newly-diagnosed HIV.
Int J STD AIDS
2015
26422086
Bacteremia caused by a mecA-positive oxacillin-susceptible Staphylococcus aureus strain with inducible resistance.
Diagn Microbiol Infect Dis
2015
27467917
Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression.
Oncoimmunology
2015
25971300
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
J Natl Cancer Inst
2015
25728150
Predictors of asymptomatic Clostridium difficile colonization on hospital admission.
Am J Infect Control
2015
24938283
Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy.
Cancer Immunol Res
2014
25465288
Therapeutic targets in subependymoma.
J Neuroimmunol
2014
24974128
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
J Natl Cancer Inst
2014
23636127
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Cancer Res
2013
23876636
Perspectives of family physicians on the care of uninsured pregnant women.
J Obstet Gynaecol Can
2013
21792892
The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.
Int J Cancer
2012
23013619
Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
Oncotarget
2012
22753228
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Neuro Oncol
2012
22488042
The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.
Oncotarget
2012
21490182
Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.
Clin Cancer Res
2011
21283755
Hypoxia potentiates glioma-mediated immunosuppression.
PLoS One
2011
20053772
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
Mol Cancer Ther
2010
20921210
Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.
Clin Cancer Res
2010
20667896
Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
Neuro Oncol
2010
20388845
Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.
Clin Cancer Res
2010
20068105
Glioma-associated cancer-initiating cells induce immunosuppression.
Clin Cancer Res
2010
1 - 50 of 78
Column Actions
Search
Recommended Authors
Zhiyuan Mao
College of Life Science and Engineering, Southwest Jiaotong University
Career Start Year
2015
Number of shared co-authors
0
Eric Song
Yale University
Career Start Year
2012
Number of shared co-authors
0
Bo Liu
Henan University
Career Start Year
2010
Number of shared co-authors
0
Tobias Weiss
Westlake University
Career Start Year
2009
Number of shared co-authors
0
Jianying Zhang
City of Hope National Medical Center
Career Start Year
2009
Number of shared co-authors
0
Zhaoqi Yan
University of Illinois College of Medicine Rockford
Career Start Year
2007
Number of shared co-authors
0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year
2006
Number of shared co-authors
0
Ke Jin
West China Hospital, Sichuan University
Career Start Year
2005
Number of shared co-authors
0
Dhiraj Kumar
Johns Hopkins University School of Medicine
Career Start Year
2004
Number of shared co-authors
0
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year
2004
Number of shared co-authors
0
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year
2003
Number of shared co-authors
0
Philip O Scumpia
David Geffen School of Medicine, University of California Los Angeles
Career Start Year
2002
Number of shared co-authors
0
Sun Jung Lee
College of Medicine, The Catholic University of Korea
Career Start Year
2000
Number of shared co-authors
0
David J Liewehr
Center for Cancer Research
Career Start Year
1999
Number of shared co-authors
0
Rong-Rong Huang
Stomatology Hospital, Zhejiang University School of Medicine
Career Start Year
1998
Number of shared co-authors
0
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year
1998
Number of shared co-authors
1
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Career Start Year
1997
Number of shared co-authors
0
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year
1997
Number of shared co-authors
0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
1
Hao Pan
Hangzhou First People's Hospital Affiliated to Zhejiang University
Career Start Year
1995
Number of shared co-authors
0
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year
1993
Number of shared co-authors
0
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year
1993
Number of shared co-authors
0
Seung Hoon Lee
Korea University College of Medicine, Korea University Ansan Hospital
Career Start Year
1993
Number of shared co-authors
1
Huy Nguyen
The University of Danang-University of Science and Technology
Career Start Year
1993
Number of shared co-authors
0
Zhiqiang An
Zhengzhou University
Career Start Year
1992
Number of shared co-authors
1
Kaoru Saijo
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year
1988
Number of shared co-authors
0
Michael Weller
University Hospital and University of Zurich
Career Start Year
1987
Number of shared co-authors
10
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year
1983
Number of shared co-authors
6
Karl Frei
University Hospital Zurich
Career Start Year
1982
Number of shared co-authors
0
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year
1970
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers
39
Jun Wei
The University of Texas MD Anderson Cancer Center
Co-authored papers
28
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers
22
Waldemar Priebe
The University of Texas MD Anderson Cancer Center
Co-authored papers
15
Qingyi Wei
South China University of Technology
Co-authored papers
14
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
13
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers
10
Yuhui Yang
Xuanwu Hospital, Capital Medical University
Co-authored papers
5
Tiffany Doucette
Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
Co-authored papers
5
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
5
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
John F de Groot
Co-authored papers
4
Moshe Talpaz
University of Michigan Rogel Cancer Center.
Co-authored papers
3
Khatri Latha
Baylor College of Medicine
Co-authored papers
3
Howard Colman
Huntsman Cancer Institute, University of Utah
Co-authored papers
2
Verlene Henry
The MD Anderson Cancer Center
Co-authored papers
2
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers
2
Erik P Sulman
NYU Grossman School of Medicine
Co-authored papers
2
Jason T Huse
Co-authored papers
2
Adam M Sonabend
Northwestern University
Co-authored papers
1
Jinbo Yang
School of Medicine and Pharmacy, Ocean University of China
Co-authored papers
1
Me-Linh Luong
Centre Hospitalier de l'Universite de Montreal
Co-authored papers
1
Suyun Huang
Virginia Commonwealth University
Co-authored papers
1
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers
1
Kevin Beccaria
Hopital Universitaire Necker-Enfants Malades
Co-authored papers
1
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers
1
Dana Pe'er
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Co-authored papers
1
1 - 30